

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to microtubule (GO:0035372) | 6.09012318 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.70796544 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.70796544 |
| 4 | protein localization to kinetochore (GO:0034501) | 5.45518142 |
| 5 | protein localization to chromosome, centromeric region (GO:0071459) | 5.07607136 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.43354049 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.43354049 |
| 8 | regulation of histone H3-K27 methylation (GO:0061085) | 4.30370197 |
| 9 | histone H3-K36 demethylation (GO:0070544) | 4.28994351 |
| 10 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 4.00796183 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.97033026 |
| 12 | low-density lipoprotein particle clearance (GO:0034383) | 3.74251432 |
| 13 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.67719509 |
| 14 | iron ion import (GO:0097286) | 3.63453178 |
| 15 | growth hormone receptor signaling pathway (GO:0060396) | 3.60726660 |
| 16 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.60087868 |
| 17 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 3.60039216 |
| 18 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.57035177 |
| 19 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.53266941 |
| 20 | positive regulation of histone deacetylation (GO:0031065) | 3.48480430 |
| 21 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.47118715 |
| 22 | nuclear pore complex assembly (GO:0051292) | 3.39998215 |
| 23 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.39775692 |
| 24 | positive regulation of nuclease activity (GO:0032075) | 3.38272866 |
| 25 | regulation of cholesterol homeostasis (GO:2000188) | 3.37891976 |
| 26 | apoptotic cell clearance (GO:0043277) | 3.33842607 |
| 27 | lysine catabolic process (GO:0006554) | 3.31667771 |
| 28 | lysine metabolic process (GO:0006553) | 3.31667771 |
| 29 | regulation of translational fidelity (GO:0006450) | 3.31281198 |
| 30 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.30335228 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 3.28115639 |
| 32 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.28033860 |
| 33 | regulation of cholesterol storage (GO:0010885) | 3.24170641 |
| 34 | amyloid precursor protein catabolic process (GO:0042987) | 3.22599665 |
| 35 | snRNA metabolic process (GO:0016073) | 3.20898086 |
| 36 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.18531612 |
| 37 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.17208728 |
| 38 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.16770953 |
| 39 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.15069105 |
| 40 | protein retention in ER lumen (GO:0006621) | 3.14138728 |
| 41 | protein localization to endosome (GO:0036010) | 3.10279192 |
| 42 | cellular response to growth hormone stimulus (GO:0071378) | 3.08836475 |
| 43 | regulation of nuclease activity (GO:0032069) | 3.06225182 |
| 44 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.05994981 |
| 45 | norepinephrine metabolic process (GO:0042415) | 3.05703123 |
| 46 | proline biosynthetic process (GO:0006561) | 3.04634501 |
| 47 | nuclear pore organization (GO:0006999) | 3.02756237 |
| 48 | activation of Rac GTPase activity (GO:0032863) | 3.00851525 |
| 49 | valine metabolic process (GO:0006573) | 2.98421927 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 2.97069798 |
| 51 | snRNA processing (GO:0016180) | 2.95237718 |
| 52 | sulfur amino acid catabolic process (GO:0000098) | 2.94889842 |
| 53 | corticosteroid receptor signaling pathway (GO:0031958) | 2.94345998 |
| 54 | cellular response to unfolded protein (GO:0034620) | 2.91495982 |
| 55 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.91153070 |
| 56 | mitochondrial fusion (GO:0008053) | 2.90128477 |
| 57 | COPII vesicle coating (GO:0048208) | 2.88225865 |
| 58 | cell adhesion mediated by integrin (GO:0033627) | 2.87293214 |
| 59 | vesicle coating (GO:0006901) | 2.86498375 |
| 60 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.86234081 |
| 61 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.86131348 |
| 62 | ER-nucleus signaling pathway (GO:0006984) | 2.85155862 |
| 63 | negative regulation of cell size (GO:0045792) | 2.84108591 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 2.83798399 |
| 65 | negative regulation of fatty acid transport (GO:2000192) | 2.83199012 |
| 66 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.83146546 |
| 67 | negative regulation of lipid transport (GO:0032369) | 2.81891594 |
| 68 | 4-hydroxyproline metabolic process (GO:0019471) | 2.81586222 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.80612523 |
| 70 | ear development (GO:0043583) | 2.79945696 |
| 71 | sexual reproduction (GO:0019953) | 2.78545182 |
| 72 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.76705082 |
| 73 | protein carboxylation (GO:0018214) | 2.76705082 |
| 74 | cellular response to topologically incorrect protein (GO:0035967) | 2.74868896 |
| 75 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74575366 |
| 76 | embryonic process involved in female pregnancy (GO:0060136) | 2.73744758 |
| 77 | membrane protein ectodomain proteolysis (GO:0006509) | 2.72205020 |
| 78 | pore complex assembly (GO:0046931) | 2.69579475 |
| 79 | hepatocyte apoptotic process (GO:0097284) | 2.67690677 |
| 80 | protein demethylation (GO:0006482) | 2.66629757 |
| 81 | protein dealkylation (GO:0008214) | 2.66629757 |
| 82 | 2-oxoglutarate metabolic process (GO:0006103) | 2.66297701 |
| 83 | positive regulation of p38MAPK cascade (GO:1900745) | 2.64315961 |
| 84 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63924957 |
| 85 | DNA duplex unwinding (GO:0032508) | 2.63350612 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.63239353 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 2.63239353 |
| 88 | histone demethylation (GO:0016577) | 2.63206104 |
| 89 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62493685 |
| 90 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.62430921 |
| 91 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.61462885 |
| 92 | urea cycle (GO:0000050) | 2.60850601 |
| 93 | urea metabolic process (GO:0019627) | 2.60850601 |
| 94 | complement activation, alternative pathway (GO:0006957) | 2.58723344 |
| 95 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.58473889 |
| 96 | protein-DNA complex disassembly (GO:0032986) | 2.56191715 |
| 97 | nucleosome disassembly (GO:0006337) | 2.56191715 |
| 98 | regulation of RNA export from nucleus (GO:0046831) | 2.54900724 |
| 99 | mRNA stabilization (GO:0048255) | 2.54012393 |
| 100 | RNA stabilization (GO:0043489) | 2.54012393 |
| 101 | zinc ion homeostasis (GO:0055069) | 2.53514630 |
| 102 | response to muramyl dipeptide (GO:0032495) | 2.52832144 |
| 103 | regulation of protein polyubiquitination (GO:1902914) | 2.52039204 |
| 104 | maternal placenta development (GO:0001893) | 2.51890371 |
| 105 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.50967507 |
| 106 | L-phenylalanine catabolic process (GO:0006559) | 2.50967507 |
| 107 | negative regulation of microtubule polymerization (GO:0031115) | 2.50829671 |
| 108 | establishment of apical/basal cell polarity (GO:0035089) | 2.50777309 |
| 109 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.50072476 |
| 110 | cellular response to virus (GO:0098586) | 2.49826066 |
| 111 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.48848538 |
| 112 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.48604551 |
| 113 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.48464947 |
| 114 | cellular zinc ion homeostasis (GO:0006882) | 2.47597161 |
| 115 | plasma lipoprotein particle clearance (GO:0034381) | 2.47585963 |
| 116 | macroautophagy (GO:0016236) | 2.47474312 |
| 117 | positive regulation of fatty acid oxidation (GO:0046321) | 2.47364100 |
| 118 | regulation of hippo signaling (GO:0035330) | 2.47089843 |
| 119 | DNA geometric change (GO:0032392) | 2.46063254 |
| 120 | regulation of fatty acid oxidation (GO:0046320) | 2.46041502 |
| 121 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.45193998 |
| 122 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.42963928 |
| 123 | morphogenesis of an endothelium (GO:0003159) | 2.42736185 |
| 124 | endothelial tube morphogenesis (GO:0061154) | 2.42736185 |
| 125 | heparin metabolic process (GO:0030202) | 2.42488532 |
| 126 | heparin biosynthetic process (GO:0030210) | 2.42488532 |
| 127 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.42109281 |
| 128 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.42091931 |
| 129 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.41945858 |
| 130 | phospholipid homeostasis (GO:0055091) | 2.41681919 |
| 131 | pentose-phosphate shunt (GO:0006098) | 2.41466480 |
| 132 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.40937687 |
| 133 | histone lysine demethylation (GO:0070076) | 2.40214177 |
| 134 | regulation of defense response to virus by virus (GO:0050690) | 2.39039255 |
| 135 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.38636326 |
| 136 | interferon-gamma secretion (GO:0072643) | 2.37940238 |
| 137 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.37923916 |
| 138 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.37821174 |
| 139 | negative regulation of viral release from host cell (GO:1902187) | 2.37194951 |
| 140 | stress fiber assembly (GO:0043149) | 2.36102854 |
| 141 | mitotic cell cycle arrest (GO:0071850) | 2.35706606 |
| 142 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.35555669 |
| 143 | diol metabolic process (GO:0034311) | 2.35493893 |
| 144 | embryonic eye morphogenesis (GO:0048048) | 2.35406135 |
| 145 | sphingomyelin metabolic process (GO:0006684) | 2.34929196 |
| 146 | mannose metabolic process (GO:0006013) | 2.34560419 |
| 147 | positive regulation of lipid catabolic process (GO:0050996) | 2.34493864 |
| 148 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.34415215 |
| 149 | positive regulation of protein deacetylation (GO:0090312) | 2.33783329 |
| 150 | fatty acid transmembrane transport (GO:1902001) | 2.33756957 |
| 151 | fatty acid homeostasis (GO:0055089) | 2.33579462 |
| 152 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.33336131 |
| 153 | basement membrane organization (GO:0071711) | 2.32854285 |
| 154 | regulation of protein activation cascade (GO:2000257) | 2.32641120 |
| 155 | response to endoplasmic reticulum stress (GO:0034976) | 2.32097186 |
| 156 | cellular response to interleukin-4 (GO:0071353) | 2.31916908 |
| 157 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.31323075 |
| 158 | Golgi organization (GO:0007030) | 2.31213849 |
| 159 | positive thymic T cell selection (GO:0045059) | 2.30878319 |
| 160 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.30421483 |
| 161 | kynurenine metabolic process (GO:0070189) | 2.30420331 |
| 162 | response to laminar fluid shear stress (GO:0034616) | 2.30255031 |
| 163 | negative regulation of histone methylation (GO:0031061) | 2.30174866 |
| 164 | regulation of gamma-delta T cell activation (GO:0046643) | 2.29713383 |
| 165 | regulation of complement activation (GO:0030449) | 2.29265491 |
| 166 | focal adhesion assembly (GO:0048041) | 2.28086580 |
| 167 | cell-substrate adherens junction assembly (GO:0007045) | 2.28086580 |
| 168 | semaphorin-plexin signaling pathway (GO:0071526) | 2.27759858 |
| 169 | cysteine metabolic process (GO:0006534) | 2.27695257 |
| 170 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.27636656 |
| 171 | oxaloacetate metabolic process (GO:0006107) | 2.27529857 |
| 172 | protein localization to chromosome (GO:0034502) | 2.26838135 |
| 173 | endothelial cell morphogenesis (GO:0001886) | 2.25917132 |
| 174 | regulation of centriole replication (GO:0046599) | 2.25750877 |
| 175 | fatty acid beta-oxidation (GO:0006635) | 2.24323429 |
| 176 | negative regulation of cholesterol transport (GO:0032375) | 2.23891473 |
| 177 | negative regulation of sterol transport (GO:0032372) | 2.23891473 |
| 178 | lipoprotein metabolic process (GO:0042157) | 2.22853549 |
| 179 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.21487881 |
| 180 | nitrogen cycle metabolic process (GO:0071941) | 2.19589928 |
| 181 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.18725313 |
| 182 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.18678569 |
| 183 | response to growth hormone (GO:0060416) | 2.18434979 |
| 184 | skin morphogenesis (GO:0043589) | 2.17802952 |
| 185 | peptidyl-lysine dimethylation (GO:0018027) | 2.17516046 |
| 186 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.16977069 |
| 187 | fatty acid oxidation (GO:0019395) | 2.15939481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.27469185 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.87575655 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20181028 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18215384 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.16264263 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.95163505 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.86210679 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68795515 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67499852 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.51916387 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51230906 |
| 12 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 2.33884121 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26719987 |
| 14 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.24321357 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.14323057 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10492344 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08087473 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07297520 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85657587 |
| 20 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81976787 |
| 21 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77882965 |
| 22 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.75424543 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74872896 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.74851663 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74066919 |
| 26 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.70189179 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70082106 |
| 28 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.67271511 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67017947 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.65657980 |
| 31 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.64877368 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.64656522 |
| 33 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.64077250 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63511443 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62838239 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62602411 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60573162 |
| 38 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.60167460 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59223797 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57735492 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57202777 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54714572 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.53635068 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.53467472 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53238643 |
| 46 | * MAF_26560356_Chip-Seq_TH1_Human | 1.52658652 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52351222 |
| 48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.51972647 |
| 49 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.51666598 |
| 50 | ATF3_27146783_Chip-Seq_COLON_Human | 1.51664275 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51018785 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50214458 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49488932 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.49345601 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47907420 |
| 56 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.47741299 |
| 57 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47483580 |
| 58 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.46882805 |
| 59 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46156910 |
| 60 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.45153660 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44260955 |
| 62 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.44049721 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.43745047 |
| 64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.40941397 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40916325 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39960457 |
| 67 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39924019 |
| 68 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.39582669 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39137266 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38598567 |
| 71 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37159930 |
| 72 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36802269 |
| 73 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36629348 |
| 74 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.34148592 |
| 75 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.33873599 |
| 76 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30208059 |
| 77 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29625616 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.27422819 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26648429 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25022572 |
| 81 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24229786 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.21447693 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21206026 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20069199 |
| 85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19630394 |
| 86 | * P68_20966046_ChIP-Seq_HELA_Human | 1.18384971 |
| 87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17845885 |
| 88 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17542824 |
| 89 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.17542327 |
| 90 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17481810 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17259231 |
| 92 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.16485675 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16251671 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15967698 |
| 95 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15914758 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15337327 |
| 97 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.14461911 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14165063 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 1.13542936 |
| 100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13269692 |
| 101 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12702463 |
| 102 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12702463 |
| 103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12426189 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11848748 |
| 105 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11470607 |
| 106 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.10927304 |
| 107 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10905747 |
| 108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10800255 |
| 109 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07766162 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 1.07277009 |
| 111 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07227780 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06730691 |
| 113 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06536932 |
| 114 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06164768 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05791308 |
| 116 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04861961 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04608133 |
| 118 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.03709269 |
| 119 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.02875358 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01962361 |
| 121 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01227163 |
| 122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01134358 |
| 123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.01123798 |
| 124 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00413420 |
| 125 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.00249440 |
| 126 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00237695 |
| 127 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00148138 |
| 128 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99690429 |
| 129 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99335092 |
| 130 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99212458 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99205193 |
| 132 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.98920710 |
| 133 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98355635 |
| 134 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98236763 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98231346 |
| 136 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98214341 |
| 137 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97540780 |
| 138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96847267 |
| 139 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96474009 |
| 140 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.96295939 |
| 141 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95785844 |
| 142 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94612737 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94184679 |
| 144 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93949741 |
| 145 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93114374 |
| 146 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91470178 |
| 147 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91470178 |
| 148 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90717052 |
| 149 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.90441762 |
| 150 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89621005 |
| 151 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88175464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.96919012 |
| 2 | MP0002009_preneoplasia | 3.17830204 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.04820190 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.02785318 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.88850907 |
| 6 | MP0005360_urolithiasis | 2.84790788 |
| 7 | MP0005451_abnormal_body_composition | 2.71170053 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 2.64637033 |
| 9 | MP0009840_abnormal_foam_cell | 2.58081626 |
| 10 | MP0005365_abnormal_bile_salt | 2.51683289 |
| 11 | MP0005409_darkened_coat_color | 2.43379610 |
| 12 | MP0001348_abnormal_lacrimal_gland | 2.30610945 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.25970071 |
| 14 | MP0004381_abnormal_hair_follicle | 2.25004630 |
| 15 | MP0003329_amyloid_beta_deposits | 2.23681010 |
| 16 | MP0004233_abnormal_muscle_weight | 2.16317111 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.13949312 |
| 18 | MP0003252_abnormal_bile_duct | 2.13261604 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.01042193 |
| 20 | MP0000537_abnormal_urethra_morphology | 2.00918809 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.00576746 |
| 22 | MP0000015_abnormal_ear_pigmentation | 1.95481712 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.90786671 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.89943657 |
| 25 | MP0003303_peritoneal_inflammation | 1.88819780 |
| 26 | MP0005076_abnormal_cell_differentiation | 1.85488338 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.76407991 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.73238772 |
| 29 | MP0006054_spinal_hemorrhage | 1.71814445 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.65102582 |
| 31 | MP0000013_abnormal_adipose_tissue | 1.56476275 |
| 32 | MP0000609_abnormal_liver_physiology | 1.54278090 |
| 33 | MP0004130_abnormal_muscle_cell | 1.52877348 |
| 34 | MP0000383_abnormal_hair_follicle | 1.52662912 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.49633758 |
| 36 | MP0004947_skin_inflammation | 1.47705771 |
| 37 | MP0005275_abnormal_skin_tensile | 1.46942534 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.43931900 |
| 39 | MP0005023_abnormal_wound_healing | 1.43788820 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.40528327 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.40199451 |
| 42 | MP0003111_abnormal_nucleus_morphology | 1.39196987 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.35490430 |
| 44 | MP0005501_abnormal_skin_physiology | 1.35365875 |
| 45 | MP0003693_abnormal_embryo_hatching | 1.34329667 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.32078054 |
| 47 | MP0003045_fibrosis | 1.30407694 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.30391132 |
| 49 | MP0005248_abnormal_Harderian_gland | 1.29551611 |
| 50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.29521328 |
| 51 | MP0003091_abnormal_cell_migration | 1.28899389 |
| 52 | MP0005171_absent_coat_pigmentation | 1.28454744 |
| 53 | MP0000377_abnormal_hair_follicle | 1.28319210 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.25748278 |
| 55 | MP0003077_abnormal_cell_cycle | 1.25450622 |
| 56 | MP0005375_adipose_tissue_phenotype | 1.23329950 |
| 57 | MP0001243_abnormal_dermal_layer | 1.21450930 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.20299917 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.19505776 |
| 60 | MP0010307_abnormal_tumor_latency | 1.19494286 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 1.18018900 |
| 62 | MP0003959_abnormal_lean_body | 1.17003984 |
| 63 | MP0009278_abnormal_bone_marrow | 1.16851949 |
| 64 | MP0001216_abnormal_epidermal_layer | 1.16547720 |
| 65 | MP0001849_ear_inflammation | 1.16245732 |
| 66 | MP0001756_abnormal_urination | 1.15433433 |
| 67 | MP0001958_emphysema | 1.13311950 |
| 68 | MP0010368_abnormal_lymphatic_system | 1.11798819 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.10547967 |
| 70 | MP0005083_abnormal_biliary_tract | 1.09044308 |
| 71 | MP0000685_abnormal_immune_system | 1.07591775 |
| 72 | MP0002118_abnormal_lipid_homeostasis | 1.06609097 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 1.06258403 |
| 74 | MP0002168_other_aberrant_phenotype | 1.05586211 |
| 75 | MP0003763_abnormal_thymus_physiology | 1.05508930 |
| 76 | MP0009931_abnormal_skin_appearance | 1.05219511 |
| 77 | MP0004197_abnormal_fetal_growth/weight/ | 1.03600705 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 1.03289977 |
| 79 | MP0003172_abnormal_lysosome_physiology | 1.02805645 |
| 80 | MP0000490_abnormal_crypts_of | 1.02731817 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.01153046 |
| 82 | MP0000604_amyloidosis | 1.00797892 |
| 83 | MP0002396_abnormal_hematopoietic_system | 0.99733186 |
| 84 | MP0003279_aneurysm | 0.99458150 |
| 85 | MP0000627_abnormal_mammary_gland | 0.98853671 |
| 86 | MP0000358_abnormal_cell_content/ | 0.98804724 |
| 87 | MP0002796_impaired_skin_barrier | 0.98215472 |
| 88 | MP0000598_abnormal_liver_morphology | 0.97196883 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.96484500 |
| 90 | MP0002086_abnormal_extraembryonic_tissu | 0.95900599 |
| 91 | MP0005332_abnormal_amino_acid | 0.95540817 |
| 92 | MP0003436_decreased_susceptibility_to | 0.95210412 |
| 93 | MP0000858_altered_metastatic_potential | 0.94052349 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.93933158 |
| 95 | MP0005174_abnormal_tail_pigmentation | 0.93253198 |
| 96 | MP0010094_abnormal_chromosome_stability | 0.93219783 |
| 97 | MP0005197_abnormal_uvea_morphology | 0.92765794 |
| 98 | MP0008007_abnormal_cellular_replicative | 0.92619147 |
| 99 | MP0005464_abnormal_platelet_physiology | 0.91717396 |
| 100 | MP0003984_embryonic_growth_retardation | 0.90537123 |
| 101 | MP0000733_abnormal_muscle_development | 0.90229497 |
| 102 | MP0003283_abnormal_digestive_organ | 0.90190932 |
| 103 | MP0005670_abnormal_white_adipose | 0.90129783 |
| 104 | MP0001835_abnormal_antigen_presentation | 0.88609570 |
| 105 | MP0002060_abnormal_skin_morphology | 0.87839427 |
| 106 | MP0006082_CNS_inflammation | 0.87740565 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.87554650 |
| 108 | MP0002080_prenatal_lethality | 0.87487206 |
| 109 | MP0001919_abnormal_reproductive_system | 0.87401297 |
| 110 | MP0004272_abnormal_basement_membrane | 0.87394434 |
| 111 | MP0001661_extended_life_span | 0.86327865 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.86124101 |
| 113 | MP0002088_abnormal_embryonic_growth/wei | 0.86033648 |
| 114 | MP0002896_abnormal_bone_mineralization | 0.85481488 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.85220721 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.85134792 |
| 117 | MP0001730_embryonic_growth_arrest | 0.84751692 |
| 118 | MP0000371_diluted_coat_color | 0.84506488 |
| 119 | MP0004858_abnormal_nervous_system | 0.84203481 |
| 120 | MP0005380_embryogenesis_phenotype | 0.84200458 |
| 121 | MP0001672_abnormal_embryogenesis/_devel | 0.84200458 |
| 122 | MP0002928_abnormal_bile_duct | 0.83959331 |
| 123 | MP0001873_stomach_inflammation | 0.83648165 |
| 124 | MP0005623_abnormal_meninges_morphology | 0.83628622 |
| 125 | MP0005621_abnormal_cell_physiology | 0.83531004 |
| 126 | MP0001915_intracranial_hemorrhage | 0.83280333 |
| 127 | MP0001881_abnormal_mammary_gland | 0.81740035 |
| 128 | MP0004510_myositis | 0.81352887 |
| 129 | MP0010155_abnormal_intestine_physiology | 0.80600192 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.79893403 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.78707382 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.77933470 |
| 133 | MP0003136_yellow_coat_color | 0.77901819 |
| 134 | MP0000767_abnormal_smooth_muscle | 0.74731111 |
| 135 | MP0003195_calcinosis | 0.74634761 |
| 136 | MP0002452_abnormal_antigen_presenting | 0.74401084 |
| 137 | MP0003075_altered_response_to | 0.74010716 |
| 138 | MP0004808_abnormal_hematopoietic_stem | 0.73857235 |
| 139 | MP0002089_abnormal_postnatal_growth/wei | 0.73482218 |
| 140 | MP0002006_tumorigenesis | 0.73443800 |
| 141 | MP0005397_hematopoietic_system_phenotyp | 0.73360657 |
| 142 | MP0001545_abnormal_hematopoietic_system | 0.73360657 |
| 143 | MP0009780_abnormal_chondrocyte_physiolo | 0.73154471 |
| 144 | MP0003221_abnormal_cardiomyocyte_apopto | 0.72728648 |
| 145 | MP0000427_abnormal_hair_cycle | 0.72680257 |
| 146 | MP0009115_abnormal_fat_cell | 0.72445592 |
| 147 | MP0003806_abnormal_nucleotide_metabolis | 0.72411669 |
| 148 | MP0005257_abnormal_intraocular_pressure | 0.72119162 |
| 149 | MP0000313_abnormal_cell_death | 0.71736469 |
| 150 | MP0001790_abnormal_immune_system | 0.71651845 |
| 151 | MP0005387_immune_system_phenotype | 0.71651845 |
| 152 | MP0002693_abnormal_pancreas_physiology | 0.71603601 |
| 153 | MP0001800_abnormal_humoral_immune | 0.71502666 |
| 154 | MP0000538_abnormal_urinary_bladder | 0.71326900 |
| 155 | MP0002971_abnormal_brown_adipose | 0.71288950 |
| 156 | MP0003828_pulmonary_edema | 0.71011004 |
| 157 | MP0002332_abnormal_exercise_endurance | 0.70639589 |
| 158 | MP0005384_cellular_phenotype | 0.70327610 |
| 159 | MP0005310_abnormal_salivary_gland | 0.69456867 |
| 160 | MP0003448_altered_tumor_morphology | 0.69168773 |
| 161 | MP0002269_muscular_atrophy | 0.69159878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Entropion (HP:0000621) | 4.09342084 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.64286175 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.60318520 |
| 4 | Asymmetry of the thorax (HP:0001555) | 3.26910772 |
| 5 | Poikiloderma (HP:0001029) | 3.15157041 |
| 6 | Termporal pattern (HP:0011008) | 3.09023195 |
| 7 | Insidious onset (HP:0003587) | 3.09023195 |
| 8 | Protrusio acetabuli (HP:0003179) | 2.93493589 |
| 9 | Hypoglycemic coma (HP:0001325) | 2.91855103 |
| 10 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.89593991 |
| 11 | Sparse lateral eyebrow (HP:0005338) | 2.85769720 |
| 12 | Complement deficiency (HP:0004431) | 2.70202637 |
| 13 | Testicular atrophy (HP:0000029) | 2.66544658 |
| 14 | Hematochezia (HP:0002573) | 2.61901097 |
| 15 | Aortic aneurysm (HP:0004942) | 2.58459402 |
| 16 | Xanthomatosis (HP:0000991) | 2.56247836 |
| 17 | Long toe (HP:0010511) | 2.55164624 |
| 18 | Aneurysm (HP:0002617) | 2.54468557 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.52140887 |
| 20 | Mucopolysacchariduria (HP:0008155) | 2.52140887 |
| 21 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.51659485 |
| 22 | Shallow orbits (HP:0000586) | 2.50942056 |
| 23 | Myocardial infarction (HP:0001658) | 2.49404843 |
| 24 | Hand muscle atrophy (HP:0009130) | 2.46482460 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 2.46081591 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.43814272 |
| 27 | Mitral valve prolapse (HP:0001634) | 2.43596357 |
| 28 | Striae distensae (HP:0001065) | 2.43330933 |
| 29 | Enlarged penis (HP:0000040) | 2.43290603 |
| 30 | Persistence of primary teeth (HP:0006335) | 2.41188082 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40249997 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40249997 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40249997 |
| 34 | Long palpebral fissure (HP:0000637) | 2.38436256 |
| 35 | Premature rupture of membranes (HP:0001788) | 2.36011683 |
| 36 | Distal upper limb amyotrophy (HP:0007149) | 2.33505912 |
| 37 | Upper limb amyotrophy (HP:0009129) | 2.33505912 |
| 38 | Ankle contracture (HP:0006466) | 2.32688745 |
| 39 | Aortic dissection (HP:0002647) | 2.31608725 |
| 40 | Hyperglycemia (HP:0003074) | 2.31532867 |
| 41 | Patellar dislocation (HP:0002999) | 2.31262327 |
| 42 | Type II lissencephaly (HP:0007260) | 2.31126964 |
| 43 | Short nail (HP:0001799) | 2.30882019 |
| 44 | Personality changes (HP:0000751) | 2.27561975 |
| 45 | Elfin facies (HP:0004428) | 2.27213022 |
| 46 | Broad face (HP:0000283) | 2.26288203 |
| 47 | Insomnia (HP:0100785) | 2.25662699 |
| 48 | Cutaneous melanoma (HP:0012056) | 2.25125356 |
| 49 | Mitral stenosis (HP:0001718) | 2.24665190 |
| 50 | Renovascular hypertension (HP:0100817) | 2.24490900 |
| 51 | Cervical subluxation (HP:0003308) | 2.24331760 |
| 52 | Peritonitis (HP:0002586) | 2.23336478 |
| 53 | Micronodular cirrhosis (HP:0001413) | 2.23067193 |
| 54 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.20950393 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.18085878 |
| 56 | Pelvic girdle muscle weakness (HP:0003749) | 2.17707415 |
| 57 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.17433192 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16891611 |
| 59 | Partial agenesis of the corpus callosum (HP:0001338) | 2.16666956 |
| 60 | Ketoacidosis (HP:0001993) | 2.16654911 |
| 61 | Spina bifida occulta (HP:0003298) | 2.15347708 |
| 62 | Natal tooth (HP:0000695) | 2.14063972 |
| 63 | Dilatation of the ascending aorta (HP:0005111) | 2.12025893 |
| 64 | Abnormality of the pons (HP:0007361) | 2.11734038 |
| 65 | Cerebellar dysplasia (HP:0007033) | 2.11687686 |
| 66 | Abnormality of complement system (HP:0005339) | 2.10587734 |
| 67 | Polycythemia (HP:0001901) | 2.09864329 |
| 68 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09440591 |
| 69 | Esophageal varix (HP:0002040) | 2.08809718 |
| 70 | Hyperacusis (HP:0010780) | 2.08314597 |
| 71 | Vertebral compression fractures (HP:0002953) | 2.07006975 |
| 72 | Intrahepatic cholestasis (HP:0001406) | 2.06193659 |
| 73 | Ketosis (HP:0001946) | 2.05737564 |
| 74 | Subacute progressive viral hepatitis (HP:0006572) | 2.05178498 |
| 75 | Hypoplasia of the pons (HP:0012110) | 2.04697453 |
| 76 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.04224064 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.02862827 |
| 78 | Overriding aorta (HP:0002623) | 2.01925771 |
| 79 | Asymmetric septal hypertrophy (HP:0001670) | 2.01038212 |
| 80 | Squamous cell carcinoma (HP:0002860) | 2.00533478 |
| 81 | Right ventricular cardiomyopathy (HP:0011663) | 1.99169727 |
| 82 | Broad metatarsal (HP:0001783) | 1.99075430 |
| 83 | Pseudobulbar signs (HP:0002200) | 1.98272937 |
| 84 | Fatigue (HP:0012378) | 1.98126880 |
| 85 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.96690326 |
| 86 | Thin bony cortex (HP:0002753) | 1.96546496 |
| 87 | Abnormal hair laboratory examination (HP:0003328) | 1.96530026 |
| 88 | Flat occiput (HP:0005469) | 1.96149940 |
| 89 | Germ cell neoplasia (HP:0100728) | 1.96042690 |
| 90 | Multiple lipomas (HP:0001012) | 1.95024984 |
| 91 | Ulnar bowing (HP:0003031) | 1.94792604 |
| 92 | Deep palmar crease (HP:0006191) | 1.94483923 |
| 93 | Late onset (HP:0003584) | 1.93904340 |
| 94 | Deformed sella turcica (HP:0002681) | 1.93650640 |
| 95 | Lymphangioma (HP:0100764) | 1.93017622 |
| 96 | Abnormality of the fingertips (HP:0001211) | 1.92773903 |
| 97 | Syringomyelia (HP:0003396) | 1.92591504 |
| 98 | Spinal cord lesions (HP:0100561) | 1.92591504 |
| 99 | Dysmetric saccades (HP:0000641) | 1.92507383 |
| 100 | Hypoglycemic seizures (HP:0002173) | 1.91811054 |
| 101 | Camptodactyly of toe (HP:0001836) | 1.90897580 |
| 102 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90482664 |
| 103 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.90435978 |
| 104 | Increased connective tissue (HP:0009025) | 1.89533124 |
| 105 | Renal duplication (HP:0000075) | 1.88425701 |
| 106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.88165148 |
| 107 | Spastic diplegia (HP:0001264) | 1.87176176 |
| 108 | Prominent nose (HP:0000448) | 1.86575872 |
| 109 | Gout (HP:0001997) | 1.86054186 |
| 110 | Skin nodule (HP:0200036) | 1.85890218 |
| 111 | Systemic lupus erythematosus (HP:0002725) | 1.85272352 |
| 112 | Hyperparathyroidism (HP:0000843) | 1.85270614 |
| 113 | Insulin resistance (HP:0000855) | 1.83756702 |
| 114 | Abnormality of the nasal mucosa (HP:0000433) | 1.83639300 |
| 115 | Achilles tendon contracture (HP:0001771) | 1.83390068 |
| 116 | Flat cornea (HP:0007720) | 1.82879866 |
| 117 | Breast hypoplasia (HP:0003187) | 1.82797357 |
| 118 | IgA deficiency (HP:0002720) | 1.82316955 |
| 119 | Abnormality of the radial head (HP:0003995) | 1.81377594 |
| 120 | Cortical dysplasia (HP:0002539) | 1.81342609 |
| 121 | Dislocated radial head (HP:0003083) | 1.79908980 |
| 122 | Curly hair (HP:0002212) | 1.79608554 |
| 123 | Shoulder girdle muscle weakness (HP:0003547) | 1.79354419 |
| 124 | Melanoma (HP:0002861) | 1.79040916 |
| 125 | Rectal prolapse (HP:0002035) | 1.78662322 |
| 126 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.77346398 |
| 127 | Hypoplasia of the brainstem (HP:0002365) | 1.77346398 |
| 128 | Back pain (HP:0003418) | 1.77149000 |
| 129 | Genu recurvatum (HP:0002816) | 1.76997293 |
| 130 | Arterial tortuosity (HP:0005116) | 1.76955708 |
| 131 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.76828377 |
| 132 | Flat acetabular roof (HP:0003180) | 1.76709888 |
| 133 | Unilateral renal agenesis (HP:0000122) | 1.76168124 |
| 134 | Hypoalphalipoproteinemia (HP:0003233) | 1.75806634 |
| 135 | Severe short stature (HP:0003510) | 1.74964206 |
| 136 | Spontaneous hematomas (HP:0007420) | 1.73472206 |
| 137 | Abnormal ossification of hand bones (HP:0005921) | 1.73156375 |
| 138 | Coarse hair (HP:0002208) | 1.72533800 |
| 139 | Abnormal glucose tolerance (HP:0001952) | 1.72187739 |
| 140 | Increased CSF protein (HP:0002922) | 1.71780971 |
| 141 | Abnormal cartilage morphology (HP:0002763) | 1.71286677 |
| 142 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.70538373 |
| 143 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.70538373 |
| 144 | Increased serum ferritin (HP:0003281) | 1.70144930 |
| 145 | Hyperammonemia (HP:0001987) | 1.69975448 |
| 146 | Severe muscular hypotonia (HP:0006829) | 1.68803226 |
| 147 | Osteolytic defects of the hand bones (HP:0009699) | 1.68618650 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.68618650 |
| 149 | Progressive hearing impairment (HP:0001730) | 1.68414611 |
| 150 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.68401041 |
| 151 | Bladder diverticulum (HP:0000015) | 1.68363520 |
| 152 | Nasal polyposis (HP:0100582) | 1.68020302 |
| 153 | Global brain atrophy (HP:0002283) | 1.67844431 |
| 154 | Colitis (HP:0002583) | 1.67345171 |
| 155 | Pili torti (HP:0003777) | 1.67183219 |
| 156 | Vascular tortuosity (HP:0004948) | 1.66686929 |
| 157 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.66543834 |
| 158 | Hemorrhage of the eye (HP:0011885) | 1.65412087 |
| 159 | Orthostatic hypotension (HP:0001278) | 1.65205207 |
| 160 | Abnormality of proline metabolism (HP:0010907) | 1.64887653 |
| 161 | Hydroxyprolinuria (HP:0003080) | 1.64887653 |
| 162 | Increased density of long bones (HP:0006392) | 1.64808771 |
| 163 | Elevated alkaline phosphatase (HP:0003155) | 1.64691502 |
| 164 | Septate vagina (HP:0001153) | 1.64537008 |
| 165 | Deviation of the thumb (HP:0009603) | 1.64119253 |
| 166 | Limb-girdle muscle atrophy (HP:0003797) | 1.63665016 |
| 167 | Flattened epiphyses (HP:0003071) | 1.63327456 |
| 168 | Abnormality of purine metabolism (HP:0004352) | 1.63322907 |
| 169 | Increased mean platelet volume (HP:0011877) | 1.63223112 |
| 170 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.63140880 |
| 171 | Bowel diverticulosis (HP:0005222) | 1.62712438 |
| 172 | Sandal gap (HP:0001852) | 1.62485444 |
| 173 | Abnormality of the lower motor neuron (HP:0002366) | 1.62447359 |
| 174 | Short humerus (HP:0005792) | 1.61109730 |
| 175 | Nephritis (HP:0000123) | 1.60401816 |
| 176 | Difficulty climbing stairs (HP:0003551) | 1.60186832 |
| 177 | Spondylolisthesis (HP:0003302) | 1.59520898 |
| 178 | Patellar aplasia (HP:0006443) | 1.59480805 |
| 179 | Hepatitis (HP:0012115) | 1.59476030 |
| 180 | Basal cell carcinoma (HP:0002671) | 1.59105935 |
| 181 | Atrophic scars (HP:0001075) | 1.59078400 |
| 182 | Abnormality of oral frenula (HP:0000190) | 1.58871814 |
| 183 | Dysautonomia (HP:0002459) | 1.58312624 |
| 184 | Viral hepatitis (HP:0006562) | 1.58147485 |
| 185 | Meningioma (HP:0002858) | 1.57507913 |
| 186 | Hepatocellular carcinoma (HP:0001402) | 1.56957151 |
| 187 | Hallux valgus (HP:0001822) | 1.56338467 |
| 188 | Hypolipoproteinemia (HP:0010981) | 1.55610175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.27817875 |
| 2 | PKN2 | 3.72612610 |
| 3 | ICK | 3.39806805 |
| 4 | ERN1 | 3.20997597 |
| 5 | EEF2K | 2.81945292 |
| 6 | IRAK3 | 2.61295212 |
| 7 | SMG1 | 2.53886652 |
| 8 | FGFR4 | 2.45854089 |
| 9 | PRPF4B | 2.37488708 |
| 10 | BRD4 | 2.24821457 |
| 11 | SIK1 | 2.23961792 |
| 12 | MAP3K10 | 2.18905983 |
| 13 | PDGFRA | 2.11626772 |
| 14 | PTK6 | 2.07987717 |
| 15 | TTN | 2.07981682 |
| 16 | TSSK6 | 2.03095899 |
| 17 | RIPK1 | 1.90608347 |
| 18 | MAP4K1 | 1.87575572 |
| 19 | STK10 | 1.84830864 |
| 20 | TGFBR2 | 1.82631329 |
| 21 | LATS1 | 1.70541554 |
| 22 | FRK | 1.68737686 |
| 23 | SCYL2 | 1.64410020 |
| 24 | LRRK2 | 1.56244062 |
| 25 | STK16 | 1.55311610 |
| 26 | SRPK1 | 1.52987046 |
| 27 | EPHB1 | 1.52280422 |
| 28 | JAK1 | 1.49657419 |
| 29 | FGFR3 | 1.39685195 |
| 30 | MAP3K14 | 1.36303614 |
| 31 | TESK2 | 1.35444295 |
| 32 | PIM2 | 1.30240732 |
| 33 | TYK2 | 1.28084924 |
| 34 | KSR2 | 1.26329234 |
| 35 | PASK | 1.26324263 |
| 36 | PRKD3 | 1.25358407 |
| 37 | JAK3 | 1.23499307 |
| 38 | RET | 1.21968163 |
| 39 | PTK2 | 1.21555335 |
| 40 | NEK9 | 1.20405709 |
| 41 | BRSK2 | 1.20110804 |
| 42 | EIF2AK2 | 1.18632521 |
| 43 | SIK2 | 1.18201578 |
| 44 | FLT3 | 1.17699722 |
| 45 | ZAP70 | 1.17060181 |
| 46 | EPHA3 | 1.16254256 |
| 47 | PAK4 | 1.14852478 |
| 48 | TAOK3 | 1.13601426 |
| 49 | TBK1 | 1.13454655 |
| 50 | RPS6KB2 | 1.11048412 |
| 51 | PRKCH | 1.09554920 |
| 52 | MAPKAPK3 | 1.02427494 |
| 53 | BCKDK | 1.02273222 |
| 54 | CAMK1D | 1.01997159 |
| 55 | IRAK4 | 0.97482596 |
| 56 | JAK2 | 0.96998439 |
| 57 | MAPK15 | 0.96721588 |
| 58 | CDK7 | 0.95165356 |
| 59 | MST1R | 0.95156213 |
| 60 | FGFR2 | 0.94683322 |
| 61 | WEE1 | 0.94463012 |
| 62 | RPS6KA4 | 0.92395420 |
| 63 | CSK | 0.91789380 |
| 64 | STK3 | 0.91520641 |
| 65 | CAMKK1 | 0.87980879 |
| 66 | CDK6 | 0.87965374 |
| 67 | TAOK1 | 0.86680131 |
| 68 | MAP2K3 | 0.84574345 |
| 69 | MET | 0.83898907 |
| 70 | DYRK1B | 0.83577611 |
| 71 | RPS6KA2 | 0.83238749 |
| 72 | DDR2 | 0.79260488 |
| 73 | MTOR | 0.78141599 |
| 74 | PDGFRB | 0.78082750 |
| 75 | NEK6 | 0.76521686 |
| 76 | ITK | 0.75498222 |
| 77 | TESK1 | 0.75230746 |
| 78 | LATS2 | 0.74771913 |
| 79 | YES1 | 0.73559549 |
| 80 | RAF1 | 0.71781789 |
| 81 | LMTK2 | 0.71721420 |
| 82 | MAP3K2 | 0.71521662 |
| 83 | ALK | 0.68456868 |
| 84 | NTRK1 | 0.68402436 |
| 85 | MAP3K8 | 0.68368311 |
| 86 | BMX | 0.67040644 |
| 87 | MAP2K1 | 0.66158074 |
| 88 | CDK12 | 0.64291676 |
| 89 | MAP3K3 | 0.64136449 |
| 90 | MOS | 0.64110569 |
| 91 | EPHA2 | 0.63060667 |
| 92 | GRK6 | 0.62838709 |
| 93 | FER | 0.62643774 |
| 94 | PRKCI | 0.62432177 |
| 95 | KDR | 0.62379967 |
| 96 | PAK3 | 0.62104509 |
| 97 | MAP3K7 | 0.60553726 |
| 98 | NEK2 | 0.60458633 |
| 99 | SIK3 | 0.59329788 |
| 100 | TAOK2 | 0.59192344 |
| 101 | MARK2 | 0.56426506 |
| 102 | MAP2K2 | 0.56219496 |
| 103 | CAMK1G | 0.56061287 |
| 104 | MAPK11 | 0.55734539 |
| 105 | NEK1 | 0.54829342 |
| 106 | TLK1 | 0.54634203 |
| 107 | RPS6KA1 | 0.54067268 |
| 108 | PAK2 | 0.53843045 |
| 109 | CHUK | 0.52692009 |
| 110 | TYRO3 | 0.52688736 |
| 111 | PDK1 | 0.51843427 |
| 112 | HIPK2 | 0.51190809 |
| 113 | PDK3 | 0.49476613 |
| 114 | PDK4 | 0.49476613 |
| 115 | FGFR1 | 0.47981963 |
| 116 | PAK6 | 0.45975429 |
| 117 | MAP3K1 | 0.45279960 |
| 118 | BLK | 0.43993472 |
| 119 | CSF1R | 0.43991585 |
| 120 | TRPM7 | 0.43667191 |
| 121 | SGK3 | 0.43400171 |
| 122 | PRKD1 | 0.42064928 |
| 123 | RPS6KB1 | 0.40985854 |
| 124 | RPS6KA5 | 0.40982729 |
| 125 | ILK | 0.40794861 |
| 126 | CDK4 | 0.40783558 |
| 127 | PDPK1 | 0.39660025 |
| 128 | MAP3K9 | 0.38783375 |
| 129 | MAPK9 | 0.38744330 |
| 130 | PRKD2 | 0.37954434 |
| 131 | INSRR | 0.37413000 |
| 132 | HCK | 0.37324561 |
| 133 | DMPK | 0.37188844 |
| 134 | TTK | 0.36833884 |
| 135 | IRAK1 | 0.36818880 |
| 136 | BRSK1 | 0.36615900 |
| 137 | EGFR | 0.35354054 |
| 138 | AKT2 | 0.35341536 |
| 139 | RPS6KL1 | 0.34451637 |
| 140 | RPS6KC1 | 0.34451637 |
| 141 | PNCK | 0.34426832 |
| 142 | CHEK2 | 0.34371791 |
| 143 | IKBKE | 0.34205242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.49527802 |
| 2 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.39020955 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.36495973 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25861725 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.91359933 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.89498923 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81041977 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.78885611 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.76016346 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.73242100 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.70991411 |
| 12 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69078624 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.62764550 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57517134 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57277586 |
| 16 | Thyroid cancer_Homo sapiens_hsa05216 | 1.53988981 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53708206 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49099050 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47844107 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46013191 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42713416 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39469554 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.39422616 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.32322232 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28357319 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27555695 |
| 27 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.26757432 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26521425 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26434031 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.23074835 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23006073 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.20955954 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20754446 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.18969290 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 1.16141890 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12286552 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12276499 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.10674982 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09784164 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08715502 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05488252 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.04990495 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.04855644 |
| 44 | Focal adhesion_Homo sapiens_hsa04510 | 1.04203692 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.03753534 |
| 46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03713172 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02514121 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02460618 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02038996 |
| 50 | Measles_Homo sapiens_hsa05162 | 1.00860625 |
| 51 | Prostate cancer_Homo sapiens_hsa05215 | 1.00549658 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99813471 |
| 53 | Alcoholism_Homo sapiens_hsa05034 | 0.98158021 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97582697 |
| 55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.97340524 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97339650 |
| 57 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.97206272 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95061079 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93783410 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.93003092 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.90137992 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.89979998 |
| 63 | Spliceosome_Homo sapiens_hsa03040 | 0.89337627 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89014576 |
| 65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.88416995 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87857537 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87466299 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86846448 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86615245 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86312426 |
| 71 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.85658590 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85438200 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.83321268 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83003304 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82558840 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82150957 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82037279 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.81926096 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80495839 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79629330 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79398409 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78525846 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78312002 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77173501 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76431524 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.76079539 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75939970 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75636876 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74517614 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74487779 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74211807 |
| 92 | Leishmaniasis_Homo sapiens_hsa05140 | 0.73325020 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72479958 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72037722 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71952281 |
| 96 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71854500 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71244348 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71215139 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69917163 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68608689 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.67448375 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.67148666 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66506770 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65723055 |
| 105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65680804 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65673256 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65371060 |
| 108 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.64831183 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64546890 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.63597092 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63162682 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62525960 |
| 113 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.61891552 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61765348 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61313451 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61085115 |
| 117 | Melanoma_Homo sapiens_hsa05218 | 0.61039534 |
| 118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60959426 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60921392 |
| 120 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60743568 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60697706 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.60640101 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60415582 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59602191 |
| 125 | Hepatitis B_Homo sapiens_hsa05161 | 0.59573842 |
| 126 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59561609 |
| 127 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59103470 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.58913134 |
| 129 | Glioma_Homo sapiens_hsa05214 | 0.58200368 |
| 130 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57853974 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57738833 |
| 132 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57033564 |
| 133 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56900067 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.56336926 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.56085857 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54783518 |
| 137 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53890072 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52779962 |
| 139 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52454061 |
| 140 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52213925 |
| 141 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50734441 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48902042 |
| 143 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48676378 |
| 144 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48549683 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48430577 |
| 146 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48063057 |
| 147 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48056733 |
| 148 | Peroxisome_Homo sapiens_hsa04146 | 0.47416925 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46460396 |

